Skip to main content
. Author manuscript; available in PMC: 2024 Jul 8.
Published in final edited form as: Lancet. 2023 Jun 20;402(10396):129–140. doi: 10.1016/S0140-6736(23)00731-6

Table 2.

Infection Status and Age at Transplant, by Trigger for Diagnosis

Time interval Variable Trigger for diagnosisa p value
Family history Newborn screening Clinical illnessb
1982–2018 Total patients (n) 257 130 505
Infection status at HCT, n (%) <0·001
 Infected/Active 62 (24·1) 27 (20·8) 284 (56·2)
 Infected/Resolved 57 (22·2) 17 (13·1) 146 (28·9)
 Infected/Unknownc 5 (1·9) 0 (0·0) 18 (3·6)
 No infection 133 (51·8) 86 (66·2) 56 (11·1)
 Unknown 0 (0·0) 0 (0·0) 1 (0·2)
Age at HCT – actual        
 Days of life, median (IQR) 67·0 (29·0–151·0) 92·5 (67·0–114·0) 222·0 (167·0–311·0) <0·001
Age at HCT – categorical n (%)        
 <3·5 months old 161 (62·6) 87 (66·9) 42 (8·3) <0·001
 ≥3·5 months old 96 (37·4) 43 (33·1) 463 (91·7)
           
2010–2018 Total patients (n) 49 130 89  
Infection status at HCT, n (%)        
 Infected/Active 6 (12·2) 27 (20·8) 49 (55·1) <0·001
 Infected/Resolved 11 (22·5) 17 (13·1) 24 (27·0)
 Infected/Unknownc 0 (0·0) 0 (0·0) 1 (1·1)
 No Infection 32 (65·3) 86 (66·1) 14 (15·7)
 Unknown 0 (0·0) 0 (0·0) 1 (1·1)
Age at HCT – actual        
 Days of life, median (IQR) 76·0 (49·0–132·0) 92·5 (67·0–114·0) 252·0 (152·0–461·0) <0·001
Age at HCT – categorical, n (%)        
 <3·5 months old 31 (63·3) 87 (66·9) 8 (9·0) <0·001
 ≥3·5 months old 18 (36·7) 43 (33·1) 81 (91·0)

Infection status at HCT was evaluated based on trigger for diagnosis, with a sub-analysis (2010–2018) for the era when NBS became available.

a

Ten patients had an unknown single trigger for diagnosis identified and are therefore excluded from this analysis.

b

Typically related to infections, autoimmunity, and/or failure to thrive.

c

An infection pre-HCT was documented, but whether it was still active or had resolved at time of HCT was not recorded.

Abbreviations: FH, family history; IQR, interquartile range; NBS, newborn screening